Mark R.

Mark R. is the U.S. Strategic Accounts Lead for Rare and Ultra Rare Disease at AstraZeneca, where they continue to prioritize improving patient outcomes. Previously, Mark held various roles, including Director and Associate Director at Alexion Pharmaceuticals, as well as positions at Pfizer, Sunovion Pharmaceuticals, and Otsuka America Pharmaceutical Inc. Mark has a Bachelor of Arts degree from Southeastern Louisiana University and served as a Combat Engineer in the U.S. Army. Their extensive experience in the pharmaceutical industry spans over two decades, focused on unique therapeutic areas.